LICENSE AGREEMENT



                                by and between



                            HEAVENLYDOOR.COM, INC.



                                      and



                       INTERNEURON PHARMACEUTICALS, INC



                                     dated



                                 June 14, 2000

{PAGE}



ARTICLE I     DEFINITIONS...................................................1

ARTICLE II    LICENSE; SUBLICENSES..........................................5

    2.1.    License Grant...................................................5

    2.2.    Improvements by Interneuron.....................................5

    2.3.    Sublicenses.....................................................5

ARTICLE III   DEVELOPMENT AND COMMERCIALIZATION.............................5

    3.1.    Exchange of Information.........................................5

    3.2.    Diligence; Development and Commercialization....................6

    3.3.    Regulatory Matters..............................................6

    3.4.    Trademark.......................................................6

    3.5.    Manufacturing...................................................6

    3.6.    Adverse Events..................................................6

    3.7.    Third Party Agreements..........................................6

 ARTICLE IV   CONFIDENTIALITY AND PUBLICITY.................................6

    4.1.    Non-Disclosure and Non-Use Obligations..........................7

    4.2.    Permitted Disclosure of Proprietary Information.................7

 ARTICLE V    PAYMENTS; ROYALTIES AND REPORTS...............................8

    5.1.    License Fee.....................................................8

    5.2.    Milestone Payments..............................................8

    5.3.    Royalties; Royalty Buy-Out Option...............................9

    5.4.    Royalty Buy-Out Option.........................................11

    5.5.    Payments from Sublicensee......................................12

    5.6.    Reports; Payment of Royalty....................................12

    5.7.    Audits.........................................................13

    5.8.    Payment Exchange Rate..........................................14

    5.9.    Tax Withholding................................................14

    5.10.   Interest on Late Payments......................................14

    5.11.   Exchange Controls..............................................14

ARTICLE VI    REPRESENTATIONS AND WARRANTIES...............................15

    6.1.    HDCI Representations and Warranties............................15

    6.2.    Warranty Disclaimer............................................16

    6.3.    Investment Representations.....................................16

    6.4.    Interneuron Representations and Warranties.....................17

ARTICLE VII   PATENT MATTERS...............................................18

    7.1.    Filing, Prosecution and Maintenance of Patent Applications

              or Patents...................................................18

    7.2.    Patent Office Proceedings......................................18

    7.3.    Enforcement and Defense........................................19

    7.4.    Patent Term Extensions and Supplemental Protection

              Certificates.................................................20

ARTICLE VIII  TERM AND TERMINATION.........................................20

    8.1.    Term and Expiration............................................20

    8.2.    Termination by Notice..........................................20

    8.3.    Termination....................................................21

    8.4.    Effect of Expiration or Termination............................22

ARTICLE IX    MISCELLANEOUS................................................23

    9.1.    Force Majeure..................................................23

{PAGE}



    9.2.    Assignment.....................................................23

    9.3.    Severability...................................................23

    9.4.    Notices........................................................23

    9.5.    Applicable Law.................................................24

    9.6.    Dispute Resolution.............................................24

    9.7.    Entire Agreement...............................................24

    9.8.    Independent Contractors........................................25

    9.9.    Waiver.........................................................25

    9.10.   Headings.......................................................25

    9.11.   Counterparts...................................................25



                                       ii

{PAGE}



                               LICENSE AGREEMENT



     THIS LICENSE AGREEMENT effective as of June 14, 2000 ("Effective Date"),

by and between HEAVENLYDOOR.COM, INC. (formerly Procept, Inc.), a

corporation organized and existing under the laws of the State of Delaware and

having its principal office at 1180 Avenue of the Americas, Suite 1447, New

York, New York 10036 ("HDCI") and INTERNEURON PHARMACEUTICALS, INC., a

corporation organized and existing under the laws of the State of Delaware and

having its principal office at 99 Hayden Avenue, Suite 200, Lexington

Massachusetts  02421 ("Interneuron").



                              W I T N E S S E T H:



     WHEREAS, HDCI is the owner of the Patent Assets and HDCI Know-How, as

defined herein;



     WHEREAS, Interneuron desires to obtain exclusive worldwide license rights,

with a right to grant sublicenses, under the Patent Assets and HDCI Know-How,

and HDCI desires to grant such license to Interneuron, upon the terms and

conditions set forth herein;



     NOW, THEREFORE, in consideration of the foregoing premises and the mutual

covenants herein contained, and for other good and valuable consideration, the

receipt and sufficiency of which are hereby acknowledged, the Parties hereby

agree as follows:



                                   ARTICLE I

                                  DEFINITIONS



     Unless specifically set forth to the contrary herein, the following terms,

where used in the singular or plural, shall have the respective meanings set

forth below:



1.1.  "1933 Act" means the Securities Act of 1933, and the rules and regulations

      ----------

      promulgated thereunder, or any successor act, all as the same shall be in

      effect at the time.



1.2.  "Affiliate" shall mean (i) any corporation or business entity of which

      -----------

      more than fifty percent (50%) of the securities or other ownership

      interests representing the equity, the voting stock or general partnership

      interest are owned, controlled or held, directly or indirectly, by a

      Party; (ii) any corporation or business entity which, directly or

      indirectly, owns, controls or holds more than fifty percent (50%) (or the

      maximum ownership interest permitted by law) of the securities or other

      ownership interests representing the equity, voting stock or general

      partnership interest, of a Party or (iii) any corporation or business

      entity of which a Party has the right to acquire, directly or indirectly,

      at least fifty percent (50%) of the securities or other ownership

      interests representing the equity, voting stock or general partnership

      interest thereof.



1.3.  "Business Day" means any day that is not a Saturday or a Sunday or a day

      --------------

      on which the New York Stock Exchange is closed.



1.4.  "Calendar Quarter" shall mean the respective periods of three (3)

      ------------------

      consecutive calendar months ending on March 31, June 30, September 30 and

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC